MDL No. 2809 created for Onglyza Lawsuits

MDL No. 2809 created for Onglyza Lawsuits

Introduction

Finally, the U.S. Judicial Panel on Multidistrict Litigation gave a nod for centralization of all the federally-filed Onglyza and Kombiglyze XR lawsuits in a single U.S. District Court, Eastern District of Kentucky on 2nd February for the purpose of coordinated pretrial proceedings. The resulting MDL: 2809-In Re: Onglyza and Kombiglyze XR Products Liability Litigation is to be presided by Honorable Judge Karen K. Caldwell.

The court records show more than 80 product liability lawsuits are pending in the federal court system filed by individuals who developed congestive heart failure and other side effects accusing Bristol-Myers Squibb and AstraZeneca as the defendants.

More cases are expected to be added to this litigation as plaintiffs continue filing cases nationwide, who feel they developed heart failure or other health problems due to the lack of adequate warnings on the diabetes drug.